“…Advancements in the diagnostic strategy are urgently needed, encompassing the identification of novel markers of disease to integrate the current clinical and genetic evaluations. On the other hand, pharmacological therapy does not exist for VSCM: currently, affected individuals endure prolonged hospitalizations and surgical interventions, often becoming dependent on parenteral nutrition and bladder catheterization, surviving with highly compromised quality of life [55].…”